Ryan Weispfenning | Vice President and Head of Investor Relations |
Geoffrey Martha | Chairman and Chief Executive Officer |
Karen Parkhill | Executive Vice President and Chief Financial Officer |
Francesca DeMartino | Vice President, Investor Relations |
Sean Salmon | Executive Vice President and President of the Diabetes Operating Unit; President, Cardiovascular Portfolio |
Bob White | Executive Vice President and President, Medical Surgical Portfolio |
Brett Wall | Executive Vice President and President, Neuroscience Portfolio |
David Lewis | Morgan Stanley |
Robert Hopkins | Bank of America Merrill Lynch |
Robert Marcus | J.P. Morgan |
Lawrence Biegelsen | Wells Fargo Securities LLC |
Vijay Kumar | Evercore ISI |
Pito Chickering | Deutsche Bank |
Matthew O'Brien | Piper Sandler |
Joanne Weunsch | Citigroup |
Joshua Jennings | Cowen and Company |
Matthew Taylor | UBS Equities |
Matthew Miksic | Credit Suisse |
Danielle Antalffy | SVB Leerink |
Good morning and welcome to Medtronic's fiscal year 2021 third quarter earnings video webcast. I'm Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations.
Before we start the prepared remarks, I'm going to share with you a few details to keep in mind about today's webcast: Joining me today are Geoff Martha, Medtronic Chairman and Chief Executive Officer, and Karen Parkhill, Medtronic Chief Financial Officer. Geoff and Karen will provide comments on the results of our third quarter, which ended on January 29, 2021. After our prepared remarks, we'll take questions from the sell side analysts that cover the company, and today's event should last about an hour.